May 31, 2026 at 8:22 PM#6
Following this thread closely. GLP-1 and atrial is something I'm actively working through.
Last edited: May 31, 2026 at 9:22 PM
43 20rachel_ABQ, traveltech_sara, AttorneyGrant and 40 others
Reply Quote Save Share Report
May 31, 2026 at 8:39 PM#7
As a healthcare provider, I want to add some clinical context to this discussion on GLP-1 and atrial fibrillation risk .
Building on what hank_denver said — the evidence base here is well-established. The key publications to reference are from the SELECT program[1].
Key clinical points:
- Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
- Side effect profile is predictable and usually manageable with standard protocols
- Monitoring should include baseline labs and follow-up at 3-month intervals
- Patient education significantly improves outcomes and adherence
Standard disclaimer: this is educational, not individualized medical advice.
References:
[1] See thread title for relevant study identification.
[1] See thread title for relevant study identification.
11 2alex_tucson, kevin_tulsa, Dr.PainCLE and 8 others
Reply Quote Save Share Report
May 31, 2026 at 8:56 PM#8
Reading this thread on GLP-1 and atrial hits close to home. Night shift nurse — I started at 299 lbs and felt like I would tried everything.
15 months on tirz and I am a different person. Not just the 74 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about GLP-1 and atrial — take the leap. It was the best health decision I have ever made. ❤️
50 15hans_munich, jason_sac26, chris_chi24 and 47 others
Reply Quote Save Share Report
May 31, 2026 at 9:13 PM#9
andrew_nyc — that is really helpful context on GLP-1 and atrial. Follow-up question: what labs did your doctor order to monitor this?
I am in a similar situation (just started) and trying to set realistic expectations.
Last edited: Jun 1, 2026 at 3:13 AM
25 23SleepDoc_PDX, RegAffairsDC, BiostatsBrad and 22 others
Reply Quote Save Share Report
May 31, 2026 at 9:30 PM#10
To answer julia.endo's question specifically:
From a clinical standpoint, GLP-1 and atrial fibrillation is an area where we have good evidence.
The short answer: baseline labs + quarterly monitoring is the standard of care.
The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.
9 7BethLabQueen, ChrisMacros, KetoKyle and 6 others
Reply Quote Save Share Report